PAR paradigm biopharmaceuticals limited..

Ann: Loyalty and Piggyback Options Program, page-468

  1. 10,383 Posts.
    lightbulb Created with Sketch. 1414
    100% vol is appropriate given near term catalysts.

    The chance of no funding news and/or regional deal(s) as we commence P3 (OA-012) is very very slim IMO.

    How the market reacts to it will be based on details itself. Even a modest deal that shows they can in fact monetise the asset should see the share price start +$1. A deal made under good terms that recognises the LT proposition means something even more.



 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
31.5¢
Change
-0.020(5.97%)
Mkt cap ! $122.6M
Open High Low Value Volume
33.5¢ 34.0¢ 31.5¢ $187.0K 573.3K

Buyers (Bids)

No. Vol. Price($)
5 55413 31.5¢
 

Sellers (Offers)

Price($) Vol. No.
32.0¢ 23498 3
View Market Depth
Last trade - 14.48pm 27/06/2025 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.